Knockdown of PGC1α in control myoblasts causes myotube hypotrophy, while ERRα phytoestrogen agonists restore a “healthy” myotube phenotype to FSHD myoblasts (Banerji et al, 2019). This evidence concerns the gene ESRRA and facioscapulohumeral muscular dystrophy.